Literature DB >> 13437258

Outbreak of aseptic meningitis (meningoencephalitis) with rubelliform rash: Toronto, 1956.

R A LAFOREST, G A MCNAUGHTON, A J BEALE, M CLARKE, N DAVIS, I SULTANIAN, A J RHODES.   

Abstract

Entities:  

Keywords:  MENINGOENCEPHALITIS/in infant and child; SKIN DISEASES/in infant and child

Mesh：

Year:  1957        PMID： 13437258      PMCID： PMC1823849     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN： 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  11 in total

1.  Aspects meningitis; evidence for the etiologic role of Coxsackie B and orphan viruses.

Authors:  A J RHODES; A BEALE
Journal:  Ann N Y Acad Sci       Date:  1957-04-19       Impact factor: 5.691

2.  Recently classified types of Coxsackie virus, group A; behavior in tissue culture.

Authors:  G M SICKLES; M MUTTERER; P FEORINO; H PLAGER
Journal:  Proc Soc Exp Biol Med       Date:  1955-11

3.  Isolation of viruses related to Echo virus type 9 from outbreaks of aseptic meningitis.

Authors:  G P BOISSARD; L J STOKES; A D MACRAE; F O MACCALLUM
Journal:  Lancet       Date:  1957-03-09       Impact factor: 79.321

4.  Isolation of ECHO virus type 6 during outbreak of seasonal aseptic meningitis.

Authors:  A L BARRON; S COHEN; D T KARZON; W WINKELSTEIN
Journal:  J Am Med Assoc       Date:  1956-12-01

5.  Association of echo virus type 6 with aseptic meningitis.

Authors:  D C DAVIS; J L MELNICK
Journal:  Proc Soc Exp Biol Med       Date:  1956 Aug-Sep

6.  Recovery of a virus from cases of an epidemic exanthem associated with meningitis.

Authors:  B SNELL; D A TYRRELL
Journal:  Lancet       Date:  1956-11-17       Impact factor: 79.321

7.  An unusual illness in young children associated with an enteric virus.

Authors:  M CRAWFORD; A D MACRAE; J N O'REILLY
Journal:  Arch Dis Child       Date:  1956-06       Impact factor: 3.791

8.  Monolayer tissue cultures. I. Preparation and standardization of suspensions of trypsin-dispersed monkey kidney cells.

Authors:  J S YOUNGNER
Journal:  Proc Soc Exp Biol Med       Date:  1954-02

9.  Cytopathogenic agents isolated from patients during an unusual epidemic exanthem.

Authors:  F A NEVA; J F ENDERS
Journal:  J Immunol       Date:  1954-04       Impact factor: 5.422

10.  Further observations on an epidemic of aseptic meningitis at Port Augusta.

Authors:  J S COVERNTON; J A MILES
Journal:  Med J Aust       Date:  1953-12-12       Impact factor: 7.738
View more
  9 in total

1.  [ECHO viruses; a survey of their nature and their current significance in clinical medicine].

Authors:  H A WENNER
Journal:  Klin Wochenschr       Date:  1959-04-01

2.  [Study on ECHO virus 9 infections].

Authors:  L LAFLEUR; B MARTINEAU
Journal:  Can Med Assoc J       Date:  1962-12-29       Impact factor: 8.262

3.  [Epidemiology of ECHO virus infections].

Authors:  A GIOVANARDI; F BERGAMINI
Journal:  Arch Gesamte Virusforsch       Date:  1963

4.  [Complement fixation reactions with the ECHO virus type 9 (Coxsackie virus type A 23)].

Authors:  O VIVELL; G LIPS
Journal:  Z Hyg Infektionskr       Date:  1958

5.  A comparative study of the prototypic Hill strain of ECHO virus, type 9, and several Coxsackie-like viruses related to it antigenically.

Authors:  I ARCHETTI; G R DUBES; H A WENNER
Journal:  Arch Gesamte Virusforsch       Date:  1959

6.  Comparative susceptibility of mammalian cells in culture to prototype enteroviruses.

Authors:  F LEHMANN-GRUBE
Journal:  Arch Gesamte Virusforsch       Date:  1961

7.  ENTEROVIRUSES.

Authors: 
Journal:  Br Med J       Date:  1958-02-08

8.  Segregation of mouse virulent and avirulent ECHO virus type 9 strains and the correlation of mouse-virulence with the "temperature" (rct/40) marker.

Authors:  M Margalith; E Margalith; L Rannon; T Goldblum; S Leventon-Kriss; N Goldblum
Journal:  Arch Gesamte Virusforsch       Date:  1967

9.  Viral infections of Toronto children during 1965. I. Enteroviral disease.

Authors:  D M McLean; M A Coleman; R P Larke; G A McNaughton
Journal:  Can Med Assoc J       Date:  1966-04-16       Impact factor: 8.262
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.